Search

Kathleen Kahler Fonda

Examiner (ID: 16259)

Most Active Art Unit
1623
Art Unit(s)
1623, 1621, 1211, 1622, 1803
Total Applications
685
Issued Applications
444
Pending Applications
93
Abandoned Applications
148

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19931732 [patent_doc_number] => 12304929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Recombinant RSV live vaccine strain and the preparing method thereof [patent_app_type] => utility [patent_app_number] => 17/717504 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 6220 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717504 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/717504
Recombinant RSV live vaccine strain and the preparing method thereof Apr 10, 2022 Issued
Array ( [id] => 19201471 [patent_doc_number] => 20240173370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => CONTROLLED RELEASE OF BACTERIOPHAGE TO TREAT IMPLANT INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/552406 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4259 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552406 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/552406
CONTROLLED RELEASE OF BACTERIOPHAGE TO TREAT IMPLANT INFECTIONS Mar 24, 2022 Pending
Array ( [id] => 17990175 [patent_doc_number] => 20220356212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT [patent_app_type] => utility [patent_app_number] => 17/705090 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705090 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/705090
MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT Mar 24, 2022 Abandoned
Array ( [id] => 19158019 [patent_doc_number] => 20240150726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => Method for Producing Recombinant AAV9 Virion [patent_app_type] => utility [patent_app_number] => 18/280543 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280543 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/280543
Method for Producing Recombinant AAV9 Virion Mar 7, 2022 Pending
Array ( [id] => 17895450 [patent_doc_number] => 20220305112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => NOVEL METHODS AND USES [patent_app_type] => utility [patent_app_number] => 17/680433 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680433 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680433
NOVEL METHODS AND USES Feb 24, 2022 Abandoned
Array ( [id] => 19051265 [patent_doc_number] => 20240093234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => CHIMERIC ADENOVIRAL VECTORS [patent_app_type] => utility [patent_app_number] => 18/263462 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263462 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/263462
CHIMERIC ADENOVIRAL VECTORS Jan 30, 2022 Pending
Array ( [id] => 19909289 [patent_doc_number] => 12285476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-29 [patent_title] => Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody [patent_app_type] => utility [patent_app_number] => 17/578049 [patent_app_country] => US [patent_app_date] => 2022-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578049 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/578049
Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody Jan 17, 2022 Issued
Array ( [id] => 19020581 [patent_doc_number] => 20240076752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => METHODS FOR DETECTION OF NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 18/260447 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260447 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/260447
METHODS FOR DETECTION OF NUCLEIC ACIDS Jan 4, 2022 Pending
Array ( [id] => 18818795 [patent_doc_number] => 20230393135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => Cell-Free Method For The Quantitative Measurement Of Virus Neutralizing Antibodies [patent_app_type] => utility [patent_app_number] => 18/032920 [patent_app_country] => US [patent_app_date] => 2021-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032920 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032920
Cell-Free Method For The Quantitative Measurement Of Virus Neutralizing Antibodies Nov 1, 2021 Pending
Array ( [id] => 17564411 [patent_doc_number] => 20220128560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS [patent_app_type] => utility [patent_app_number] => 17/513538 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513538 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/513538
HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS Oct 27, 2021 Abandoned
Array ( [id] => 19954436 [patent_doc_number] => 12324833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-10 [patent_title] => Recombinant severe respiratory syndrome coronavirus 2 Rbd trimer protein vaccine capable of generating broad-spectrum cross neutralization activity, and preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 18/277087 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 4573 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277087 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277087
Recombinant severe respiratory syndrome coronavirus 2 Rbd trimer protein vaccine capable of generating broad-spectrum cross neutralization activity, and preparation method and use thereof Sep 23, 2021 Issued
Array ( [id] => 18256891 [patent_doc_number] => 20230083931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => CORONAVIRUS VACCINES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/481781 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 170288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481781 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/481781
CORONAVIRUS VACCINES AND METHODS OF USE Sep 21, 2021 Pending
Array ( [id] => 17441901 [patent_doc_number] => 20220062406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/460026 [patent_app_country] => US [patent_app_date] => 2021-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460026 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/460026
IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF Aug 26, 2021 Abandoned
Array ( [id] => 19763337 [patent_doc_number] => 12221616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-11 [patent_title] => Adeno-associated virus variant capsids and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/400041 [patent_app_country] => US [patent_app_date] => 2021-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 36329 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400041 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/400041
Adeno-associated virus variant capsids and methods of use thereof Aug 10, 2021 Issued
Array ( [id] => 17400027 [patent_doc_number] => 20220042117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) [patent_app_type] => utility [patent_app_number] => 17/393742 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/393742
COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) Aug 3, 2021 Pending
Array ( [id] => 17412792 [patent_doc_number] => 20220047696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => ANTI-CORONAVIRUS VACCINES [patent_app_type] => utility [patent_app_number] => 17/389724 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389724 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/389724
Anti-coronavirus vaccines Jul 29, 2021 Issued
Array ( [id] => 18656237 [patent_doc_number] => 20230302123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => REPLICATION-DEFICIENT ADENOVIRUS [patent_app_type] => utility [patent_app_number] => 18/007364 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007364 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007364
REPLICATION-DEFICIENT ADENOVIRUS Jul 29, 2021 Pending
Array ( [id] => 18583195 [patent_doc_number] => 20230265455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES [patent_app_type] => utility [patent_app_number] => 18/017726 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017726 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017726
IMPROVED AAV-MEDIATED X-LINKED RETINOSCHISIS THERAPIES Jul 27, 2021 Pending
Array ( [id] => 19949449 [patent_doc_number] => 12320809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Method for measuring viral antigen in sample, antibody set, and reagent kit [patent_app_type] => utility [patent_app_number] => 17/387409 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5810 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/387409
Method for measuring viral antigen in sample, antibody set, and reagent kit Jul 27, 2021 Issued
Array ( [id] => 18649428 [patent_doc_number] => 20230295238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => INSULIN RECEPTOR-MEDIATED ENHANCEMENT OF GENE TRANSFER [patent_app_type] => utility [patent_app_number] => 18/017175 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017175 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017175
INSULIN RECEPTOR-MEDIATED ENHANCEMENT OF GENE TRANSFER Jul 18, 2021 Pending
Menu